Each fall, every Medicare Advantage and Part D plan mails a document that decides how much its members pay the following year, and it is due to land by September 30. The Annual Notice of Change spells out what a plan will charge and cover in 2027, from premiums and deductibles to which drugs and doctors remain in network. Set aside unread, it becomes the moment a plan quietly re-enrolls a member into a costlier or narrower version of itself on January 1, with the only escape window closing weeks later.
What the Annual Notice of Change actually discloses
The notice is not marketing. It is a required comparison between a plan’s current terms and its terms for the coming year, and the differences it reports are the ones that hit a household budget. A drug that sat in a low copay tier can move to a higher one, a monthly premium can rise, a deductible can climb, and a familiar hospital or physician group can drop out of the network. Each of those changes takes effect automatically unless the member does something about it.
The document members receive is the plan’s Annual Notice of Change, and it is meant to be read alongside the current year’s coverage rather than skimmed for the bottom-line premium. A plan can hold its premium flat while raising the deductible or reshuffling its drug list, so a single reassuring number on the first page can mask changes that cost far more over a full year of prescriptions and visits.
Because the notice describes next year’s plan, it is also the earliest reliable signal of whether a plan still fits. A member who takes a specific medication or sees a particular specialist can confirm, before any deadline, whether that drug and that provider survive into 2027, and can treat the answer as the reason to shop or stay.
A companion document, the Evidence of Coverage, spells out the full rules in detail, but the Annual Notice of Change is the short summary built specifically to highlight what is different from the prior year. That focus is the point. A member does not have to read hundreds of pages to see that a preferred drug moved tiers or a specialist left the network, because the notice isolates the year-over-year changes that actually drive cost.
Free retirement updates: Miss an enrollment or claim deadline and it may be gone. Our free Retirement Shield newsletter keeps readers ahead of the ones that matter. Get the free newsletter.
The window that closes on December 7
Reading the notice matters because the response window is fixed and short. Medicare’s fall open enrollment runs October 15 through December 7, the stretch when a member can switch Advantage plans, change Part D coverage, or move back to Original Medicare. Choices made in that window take effect January 1, and a plan must receive the request by December 7 for it to count.
Doing nothing is itself a decision. A member who ignores the notice and lets the deadline pass is automatically renewed into the changed plan for the entire year, locked to the new costs and the narrowed network until the next enrollment period comes around. There is no mid-year do-over for a member who simply disliked how the plan changed, which is what turns an unopened envelope into a full-year commitment.
One narrow exception exists, and it is easy to overstate. From January 1 through March 31, a member already enrolled in a Medicare Advantage plan may switch to a different Advantage plan or return to Original Medicare, a limited second window that does not let someone in Original Medicare newly pick an Advantage plan and does not cover standalone Part D changes. For most members weighing the notice, the October-to-December window remains the real decision point, and treating the spring window as a safety net is how people end up stuck.
The sequence is deliberate. The notice arrives by September 30 precisely so members have roughly two weeks to study it before the October 15 window opens, giving time to compare the revised plan against alternatives while there is still a way to act on the comparison.
Turning the notice into a decision
The practical move is to line up the notice against actual usage rather than against last year’s plan brochure. Checking whether current prescriptions remain covered at the same tier, whether preferred pharmacies and physicians are still in network, and whether the deductible or out-of-pocket maximum shifted converts a dense mailing into a short list of concrete questions. Those answers point directly to whether switching plans is worth the effort during the enrollment window.
Members who conclude their plan no longer fits can compare options and enroll through the official plan-comparison and enrollment tools, which show competing Advantage and Part D plans side by side for the coming year. The same tools confirm whether a new plan covers the drugs and providers a member relies on, closing the loop the notice opened.
Timing the review also guards against a quieter risk. Plans can leave a market entirely, and a non-renewal notice is not the same as an Annual Notice of Change. A member whose plan is discontinued must actively choose a new one or risk a gap in coverage, and that scenario arrives in the same fall mailing stream, which is another reason the September mail deserves attention rather than the recycling bin.
The through-line is that the notice and the deadline are two halves of one system. The Annual Notice of Change reveals what a plan will become, and the October 15 to December 7 window is the only routine chance to reject it. A member who reads the first and acts within the second keeps control of the coverage; a member who lets both slide inherits whatever the plan decided, at whatever it now costs, for a full year.
This article was produced with AI assistance and reviewed by The Money Overview editorial team.
More Financial Reading
